{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T06:31:50Z","timestamp":1794551510732,"version":"4.9.1"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Heilongjiang University of Traditional Chinese Medicine: Heilongjiang University of Chinese Medicine","award":["Grant No. 20241313050309"],"award-info":[{"award-number":["Grant No. 20241313050309"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,13]]},"abstract":"<jats:p>Beiqishen Jiangtang Granule, derived from Huangqi Liu Yi Tang and Shengmai Yin, plays a significant role for the therapy of type 2 diabetes mellitus (T2DM). However, the underlying molecular therapeutic mechanisms remain unclear. This study uses an integrated approach combining network pharmacology, molecular docking, and in vitro validation experiments to explore potential bioactive compounds, key targets, major signaling pathways, and underlying molecular mechanisms of Beiqishen Jiangtang Granule in the treatment of T2DM. In this study, network analysis was employed to screen metabolites and potential targets using the TCMSP database, followed by Gene Ontology, kyoto encyclopedia of genes and genomes enrichment analyses to predict the underlying mechanisms, and the protein encoded by the core target was docked with the active ingredient. Using a streptozotocin-induced approach, a T2DM rat model was established to evaluate the bioactivity of Beiqishen Jiangtang Granule on blood glucose levels, lipid profiles, inflammatory cytokines, gene expression, and gut microbiota composition. Network analysis identified 121 primary metabolites and 30 key targets in Beiqishen Jiangtang Granule. Integrated Gene Ontology and kyoto encyclopedia of genes and genomes analyses (27 items) predicted that Beiqishen Jiangtang Granule regulates serum contents of insulin, tumor necrosis factor-alpha, and interleukin-6, and modulates TP53, Akt, and PI3K protein expression to exert hypoglycemic effects. Animal studies confirmed Beiqishen Jiangtang Granule significant glucose-lowering action via these pathways and mRNA regulation. Additionally, Beiqishen Jiangtang Granule was shown to rebalance gut microbiota by enriching beneficial bacterial communities and suppressing the growth of harmful bacteria, aiding T2DM treatment. These findings demonstrate Beiqishen Jiangtang Granule\u2019s characterized by multiple components, targets, and pathways mechanisms in treating T2DM. Beiqishen Jiangtang Granule have a very significant therapeutic effect on T2DM by regulating the concentrations of insulin, tumor necrosis factor-alpha and interleukin-6 in serum and influencing the expressions of TP53, Akt and PI3K proteins and mRNA. In addition, Beiqishen Jiangtang Granule can also regulate the imbalance of intestinal flora related to T2DM in patients by promoting the proliferation of beneficial bacteria and inhibiting harmful bacteria, thereby assisting T2DM.<\/jats:p>","DOI":"10.1097\/md.0000000000047533","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T18:01:27Z","timestamp":1771005687000},"page":"e47533","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Insights into the potential mechanism of Beiqishen Jiangtang Granule in the treatment of type 2 diabetes nephropathy: A study based on network pharmacology, molecular docking, and biological validation"],"prefix":"10.1097","volume":"105","author":[{"given":"Meitong","family":"Pan","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4431-1129","authenticated-orcid":false,"given":"Panpan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Xinjiang Phytomedicine Resource and Utilization, Ministry of Education, Department of Pharmacy, Shihezi University, Shihezi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanping","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keke","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China"},{"name":"Department of Jiamusi, Heilongjiang University of Chinese Medicine, Jiamusi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weili","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiubo","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China"},{"name":"Department of Jiamusi, Heilongjiang University of Chinese Medicine, Jiamusi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260216","doi-asserted-by":"crossref","first-page":"115734","DOI":"10.1016\/j.biopha.2023.115734","article-title":"Diabetes mellitus: Classification, mediators, and complications; A gate to identify potential targets for the development of new effective treatments.","volume":"168","author":"Antar","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"R2-20260216","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nm.4350","article-title":"Insulin action and resistance in obesity and type 2 diabetes.","volume":"23","author":"Czech","year":"2017","journal-title":"Nat Med"},{"key":"R3-20260216","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.2337\/diabetes.52.6.1475","article-title":"The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging.","volume":"52","author":"Meigs","year":"2003","journal-title":"Diabetes"},{"key":"R4-20260216","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.2337\/dc21-S009","article-title":"Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2021.","volume":"44","author":"Amer Diabet","year":"2021","journal-title":"Diabetes Care"},{"key":"R5-20260216","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities.","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"R6-20260216","doi-asserted-by":"crossref","first-page":"e37867","DOI":"10.2196\/37867","article-title":"Mailed letter versus phone call to increase diabetic-related retinopathy screening engagement by patients in a team-based primary care practice: prospective, single-masked, randomized Trial.","volume":"25","author":"Stamenova","year":"2023","journal-title":"J Med Internet Res"},{"key":"R7-20260216","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","article-title":"The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments.","volume":"18","author":"Targher","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R8-20260216","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1161\/CIRCULATIONAHA.116.022194","article-title":"Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus - mechanisms, management, and clinical considerations.","volume":"133","author":"Low Wang","year":"2016","journal-title":"Circulation"},{"key":"R9-20260216","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"R10-20260216","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2337\/dc14-2441","article-title":"Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American diabetes association and the European association for the study of diabetes.","volume":"38","author":"Inzucchi","year":"2015","journal-title":"Diabetes Care"},{"key":"R11-20260216","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1056\/NEJMoa1600869","article-title":"Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes.","volume":"376","author":"Schauer","year":"2017","journal-title":"N Engl J Med"},{"key":"R12-20260216","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMc1600827","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes.","volume":"374","author":"Sarafidis","year":"2016","journal-title":"N Engl J Med"},{"key":"R13-20260216","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1142\/S0192415X12500656","article-title":"Treatment of diabetes using traditional Chinese medicine: past, present and future.","volume":"40","author":"Tong","year":"2012","journal-title":"Am J Chin Med"},{"key":"R14-20260216","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jep.2003.12.031","article-title":"Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus.","volume":"92","author":"Li","year":"2004","journal-title":"J Ethnopharmacol"},{"key":"R15-20260216","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(21)00213-0","article-title":"Semaglutide 2\u00b74\u2009mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial.","volume":"397","author":"Davies","year":"2021","journal-title":"Lancet"},{"key":"R16-20260216","doi-asserted-by":"crossref","first-page":"1280736","DOI":"10.3389\/fphar.2023.1280736","article-title":"Efficacy and safety of the integration of traditional Chinese medicine and western medicine in the treatment ofdiabetes-associated cognitive decline: a systematic review and meta-analysis.","volume":"14","author":"Su","year":"2023","journal-title":"Front Pharmacol"},{"key":"R17-20260216","doi-asserted-by":"crossref","first-page":"e0130550","DOI":"10.1371\/journal.pone.0130550","article-title":"The efficacy and safety of Chinese herbal medicine jinlida as add-on medication in type 2 diabetes patients ineffectively managed by metformin monotherapy: a double-blind, randomized, placebo-controlled, multicenter trial.","volume":"10","author":"Lian","year":"2015","journal-title":"PLoS One"},{"key":"R18-20260216","first-page":"699","article-title":"Study on the effects and mechanism of astragalus liuyi decoction on type 2 diabetes mellitus rats.","volume":"41","author":"Wen","year":"2018","journal-title":"J Chin Med Mater"},{"key":"R19-20260216","first-page":"15","article-title":"Effect of shengmai decoction combined with qianjin weijing decoction on lung function and quality of life of patients after surgery of lung cancer.","volume":"56","author":"Gan","year":"2024","journal-title":"New Chin Med"},{"key":"R20-20260216","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ygeno.2021.11.031","article-title":"Gene expression profiles and pathway enrichment analysis to identification of differentially expressed gene and signaling pathways in epithelial ovarian cancer based on high-throughput RNA-seq data.","volume":"114","author":"Siavoshi","year":"2022","journal-title":"Genomics"},{"key":"R21-20260216","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"R22-20260216","doi-asserted-by":"crossref","first-page":"6303063","DOI":"10.1155\/2021\/6303063","article-title":"The effectiveness of traditional chinese medicine jinlida granules on glycemic variability in newly diagnosed type 2 diabetes: a double-blinded, randomized trial.","volume":"2021","author":"Pan","year":"2021","journal-title":"J Diabetes Res"},{"key":"R23-20260216","doi-asserted-by":"crossref","first-page":"1242318","DOI":"10.3389\/fphar.2023.1242318","article-title":"A review of the botany, phytochemistry, traditional uses, pharmacology, toxicology, and quality control of the Astragalus memeranaceus.","volume":"14","author":"Wang","year":"2023","journal-title":"Front Pharmacol"},{"key":"R24-20260216","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jep.2016.05.005","article-title":"Traditional uses, botany, phytochemistry, pharmacology and toxicology of Panax notoginseng (Burk.) F.H. Chen: A review.","volume":"188","author":"Wang","year":"2016","journal-title":"J Ethnopharmacol"},{"key":"R25-20260216","doi-asserted-by":"crossref","first-page":"114759","DOI":"10.1016\/j.jep.2021.114759","article-title":"A comprehensive review of ethnopharmacology, phytochemistry, pharmacology, and pharmacokinetics of Schisandra chinensis (Turcz.) Baill. and Schisandra sphenanthera Rehd. et Wils.","volume":"284","author":"Yang","year":"2022","journal-title":"J Ethnopharmacol"},{"key":"R26-20260216","doi-asserted-by":"crossref","first-page":"130622","DOI":"10.1016\/j.ijbiomac.2024.130622","article-title":"The polysaccharides from seeds of Glycyrrhiza uralensis ameliorate metabolic disorders and restructure gut microbiota in type 2 diabetic mice.","volume":"264","author":"Ye","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"R27-20260216","doi-asserted-by":"crossref","first-page":"22959","DOI":"10.1038\/s41598-021-02248-5","article-title":"Mechanism of quercetin therapeutic targets for Alzheimer disease and type 2 diabetes mellitus.","volume":"11","author":"Zu","year":"2021","journal-title":"Sci Rep"},{"key":"R28-20260216","first-page":"150","article-title":"Anti-diabetic effect of quercetin in type 2 diabetes mellitus by regulating the microRNA-92b-3p\/EGR1 axis.","volume":"74","author":"Ke","year":"2023","journal-title":"J Physiol Pharmacol"},{"key":"R29-20260216","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.3390\/nu14061160","article-title":"Coreopsis tinctoria and its flavonoids ameliorate hyperglycemia in obese mice induced by high-fat diet.","volume":"14","author":"Zhang","year":"2022","journal-title":"Nutrients"},{"key":"R30-20260216","doi-asserted-by":"crossref","first-page":"116214","DOI":"10.1016\/j.jep.2023.116214","article-title":"Protective effects of flavonoids in Coreopsis tinctoria Nutt. in a mouse model of type 2 diabetes.","volume":"307","author":"Ma","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"R31-20260216","first-page":"1165","article-title":"Formononetin attenuates myocardial injury in diabetic mice through AKT\/FoxO1 signaling.","volume":"31","author":"Cheng","year":"2020","journal-title":"Trad Chin Drug Res Clin Pharmacol"},{"key":"R32-20260216","doi-asserted-by":"crossref","first-page":"104935","DOI":"10.1016\/j.phrs.2020.104935","article-title":"Artificial intelligence and network pharmacology based investigation of pharmacological mechanism and substance basis of Xiaokewan in treating diabetes.","volume":"159","author":"Zhu","year":"2020","journal-title":"Pharmacol Res"},{"key":"R33-20260216","doi-asserted-by":"crossref","first-page":"616378","DOI":"10.3389\/fphar.2020.616378","article-title":"Formononetin activates the Nrf2\/ARE signaling pathway via Sirt1 to improve diabetic renal fibrosis.","volume":"11","author":"Zhuang","year":"2020","journal-title":"Front Pharmacol"},{"key":"R34-20260216","first-page":"2893","article-title":"Formononetin ameliorates high glucose\u2011induced endothelial dysfunction by inhibiting the JAK\/STAT signaling pathway.","volume":"20","author":"Zhou","year":"2019","journal-title":"Mol Med Rep"},{"key":"R35-20260216","doi-asserted-by":"crossref","first-page":"eade8647","DOI":"10.1126\/scitranslmed.ade8647","article-title":"DRAK2 suppresses autophagy by phosphorylating ULK1 at Ser(56) to diminish pancreatic \u03b2 cell function upon overnutrition.","volume":"16","author":"Lu","year":"2024","journal-title":"Sci Transl Med"},{"key":"R36-20260216","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41580-025-00826-3","article-title":"Regulation and function of insulin and insulin-like growth factor receptor signalling.","volume":"26","author":"Choi","year":"2025","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R37-20260216","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1126\/science.adr4731","article-title":"Endothelial insulin resistance induced by adrenomedullin mediates obesity-associated diabetes.","volume":"387","author":"Cho","year":"2025","journal-title":"Science"},{"key":"R38-20260216","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S1043-2760(00)00272-1","article-title":"Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes.","volume":"11","author":"Moller","year":"2000","journal-title":"Trends Endocrinol Metab"},{"key":"R39-20260216","first-page":"653","article-title":"Research progress of PI3K\/AKT pathway in animal glucose metabolism.","volume":"33","author":"Sun","year":"2021","journal-title":"Chin Bullet Li Sci"},{"key":"R40-20260216","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/j.apsb.2021.10.015","article-title":"Nuclear TIGAR mediates an epigenetic and metabolic autoregulatory loop via NRF2 in cancer therapeutic resistance.","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"R41-20260216","article-title":"Characterization of metabolic phenotypes of pancreatic islet-specific TP53-induced glycolysis and apoptosis regulator (TIGAR) knockout mice [master's thesis].","author":"Wei","year":"2018"},{"key":"R42-20260216","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/13880209.2024.2351946","article-title":"Traditional Chinese medicine improved diabetic kidney disease through targeting gut microbiota.","volume":"62","author":"Wu","year":"2024","journal-title":"Pharm Biol"},{"key":"R43-20260216","doi-asserted-by":"crossref","first-page":"010502","DOI":"10.11613\/BM.2021.010502","article-title":"Sample size, power and effect size revisited: simplified and practical approaches in pre-clinical, clinical and laboratory studies.","volume":"31","author":"Serdar","year":"2021","journal-title":"Biochem Med (Zagreb)"},{"key":"R44-20260216","doi-asserted-by":"crossref","first-page":"116067","DOI":"10.1016\/j.jpba.2024.116067","article-title":"Exploration of the intestinal flora to reveal the important contribution of Radix Astragali to Huangqi Jianzhong Tang in treating chronic atrophic gastritis rats.","volume":"242","author":"Zhang","year":"2024","journal-title":"J Pharm Biomed Anal"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047533","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T16:03:00Z","timestamp":1771257780000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047533","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"assertion":[{"value":"2025-10-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}